Bumper Offer - Urjas oil Just @ Rs. 1
Dynapar 100 Suppository, a prescription drug, is manufactured in various forms such as Suppository. Muscle Pain, Toothache, Rheumatic Pain are some of its major therapeutic uses. Dynapar 100 Suppository also has some secondary and off-label uses. These are listed below.
The right dosage of Dynapar 100 Suppository depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Dynapar 100 Suppository as well, which are listed below. Such side effects of Dynapar 100 Suppository normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Dynapar 100 Suppository has a Severe effect for pregnant women and Mild effect on lactating mothers. Further, the section on Dynapar 100 Suppository related warnings talks about Dynapar 100 Suppository's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Stomach Infection, Skin Rash, Stroke must refrain from the use of Dynapar 100 Suppository since this can cause severe adverse effects. Other conditions have been mentioned below in the Dynapar 100 Suppository contraindications section.
Additionally, Dynapar 100 Suppository may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Dynapar 100 Suppository is safe while driving, and is is addictive in nature.
Dynapar 100 Suppository is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Dynapar 100 Suppository safe for pregnant women?
Pregnant women may get severe side effects after taking Dynapar. If you are pregnant, do not take Dynapar without a doctor's advice.
Is the use of Dynapar 100 Suppository safe during breastfeeding?
Side effects of Dynapar on breastfeeding women are very mild.
What is the effect of Dynapar 100 Suppository on the Kidneys?
Use of Dynapar may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Dynapar 100 Suppository on the Liver?
Dynapar may have severe effects on your liver, so do not take it without first consulting your doctor.
What is the effect of Dynapar 100 Suppository on the Heart?
Dynapar can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Dynapar 100 Suppository should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dynapar 100 Suppository unless your doctor advises you to do so -
Is this Dynapar 100 Suppository habit forming or addictive?
Dynapar 100 Suppository does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Dynapar 100 Suppository as it does not make you drowsy.
Is it safe?
Yes, but consume Dynapar 100 Suppository only on doctor's advice.
Is it able to treat mental disorders?
No, Dynapar 100 Suppository cannot treat any kind of mental disorder.
Interaction between Food and Dynapar 100 Suppository
There is no information on the effects of taking Dynapar 100 Suppository with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Dynapar 100 Suppository
Consumption of alcohol and Dynapar 100 Suppository together may have severe effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
